Canine Osteosarcoma: Welfare and Palliative Management Options

Osteosarcoma is the most common bone cancer in large and giant breed dogs, causing severe pain and requiring difficult decisions about amputation, chemotherapy, or palliative management.

Key Facts

Osteosarcoma accounts for approximately 85% of bone tumours in dogs
Large and giant breeds including Greyhounds and Irish Wolfhounds are most commonly affected
The primary tumour causes severe progressive pain through bone destruction and pathological fracture
Amputation with chemotherapy offers the best survival outcomes (median 10-12 months)
Palliative radiation and pain management can maintain quality of life without surgery

Welfare Considerations

Canine osteosarcoma causes severe, escalating bone pain that significantly compromises welfare even before pathological fracture occurs. The welfare challenge for owners and clinicians is managing this pain effectively while making difficult decisions about treatment intensity. Palliative radiation therapy significantly reduces pain in many dogs for 2-4 months and represents a meaningful welfare improvement even for dogs whose owners decline surgery. Multimodal analgesia including NSAIDs, gabapentin, and opioids is essential. Regular quality of life assessment guides the timing of euthanasia as the disease progresses.

What You Can Do

Seek urgent pain assessment and management if your dog is diagnosed with osteosarcoma
Discuss all treatment options including amputation, palliative radiation, and pain management with a specialist
Use validated quality of life scoring tools to monitor welfare and inform euthanasia timing
Consider a trial of palliative radiation therapy to assess pain response before committing to surgery
Plan ahead for euthanasia when quality of life deteriorates to avoid prolonged suffering